Product Name | MF | CAS | Details |
---|
H-Tic-[Pen-Phe-D-Trp-Orn-Tyr-Cys]-Val-OH | Details |
Pamatolol | C16H26N2O4 | 59110-35-9 | Details |
Benzaldehyde semicarbazone | C8H9N3O | 1574-10-3 | Details |
N-Boc-(R)-2-(3-thiazolidinylcarbonyl)pyrrolidine | C13H22N2O3S | 155251-72-2 | Details |
3-[1-(4-Cyanophenyl)-2,5-dioxoimidazolidin-4-yl]propanoic acid | C13H11N3O4 | 1173293-43-0 | Details |
Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
3-(4-Chlorophenyl)cyclohexan-1-one | C12H13ClO | 136333-71-6 | Details |
4-Methylumbelliferyl 3-deoxy-D-glycero-a-D-galacto-2-nonulosonic acid sodium salt | C19H19O11.Na | 123269-95-4 | Details |
5'-O-Tritylthymidine | C29H28N2O5 | 7791-71-1 | Details |
H-AVPYPQR^-OH | Details |
2',3',5'-Tri-O-acetylguanosine | C16H19N5O8 | 6979-94-8 | Details |
N-(4-Fluorophenyl)Anthranilic Acid | C13H10FNO2 | 54-60-4 | Details |
4-Oxo-4H-pyrano[2,3-c]pyridine-2-carboxylic acid hydrochloride | C9H6ClNO4 | 1909313-31-0 | Details |
cRAF antibody | Details |
4-{[3-(Methoxymethyl)phenyl]amino}pyridine-2-carbonitrile | C14H13N3O | 1275856-40-0 | Details |
2-(2,6-Dimethylpiperidin-1-yl)-N'-hydroxyethanimidamide | C9H19N3O | 1016846-03-9 | Details |
Complement C8b Blocking Peptide | Details |
Isovitexin | C21H20O10 | 38953-85-4 | Details |
[2-(Morpholine-4-sulfonyl)phenyl]methanol | C11H15NO4S | 937796-15-1 | Details |
(1-Benzylcyclohexyl)methanamine hydrochloride | C14H22ClN | 2173999-23-8 | Details |
2-Chloro-1-(5-methyl-1,2-oxazol-3-yl)ethan-1-one | C6H6ClNO2 | 1514117-75-9 | Details |
LDHB protein | Details |
Levocarnitine Related Compound A | C7H13ClNO2 | 6538-82-5 | Details |
4-Methylumbelliferyl heptanoate | C17H20O4 | 18319-92-1 | Details |
tert-Butyl 3-{[(1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]amino}pyrrolidine-1-carboxylate | C16H26N4O4 | 1803590-45-5 | Details |
5-(2-Methylpropyl)-1,4-oxazepane hydrochloride | C9H20ClNO | 2309465-86-7 | Details |
1-(3,4-Difluorophenyl)-2-methoxyethan-1-one | C9H8F2O2 | 1157136-76-9 | Details |
Goat anti Human IgA (R-PE) | Details |
tert-Butyl 2-hydroxybenzoate | C11H14O3 | 23408-05-1 | Details |
Val-Phe-Val | Details |
3-(4-Chlorophenyl)-3-methyloxolane-2,5-dione | C11H9ClO3 | 1094333-80-8 | Details |
4-[(2-Aminopyridin-3-yl)oxy]butanenitrile | C9H11N3O | 1152561-49-3 | Details |
SSH3 antibody | Details |
iRucaparib-AP6 | C46H55FN6O11 | 2410557-00-3 | Details |
Toremifene-N-oxide | C26H28ClNO2 | 163130-29-8 | Details |
(2,5-Dichlorothiophen-3-yl)methanesulfonyl chloride | C5H3Cl3O2S2 | 125897-99-6 | Details |
cis-3,4-difluoropiperidine hcl | C5H10ClF2N | 1419101-53-3 | Details |
Titanium(IV) isopropoxide | C12H28O4Ti | 546-68-9 | Details |
Prothrombin protein | Details |
4-Nitrophenyl lacto-N-tetraoside | C32H48N2O23 | 148705-09-3 | Details |
Glucagon Blocking Peptide | Details |
4-cyano-3-(trifluoromethyl)benzene-1-sulfonyl chloride | C8H3ClF3NO2S | 942199-59-9 | Details |
Tryptanthrin | C15H8N2O2 | 13220-57-0 | Details |
7-Chloro-2-phenyl-[1,2,4]triazolo[1,5-c]pyrimidine | C11H7ClN4 | 1354954-02-1 | Details |
3-Amino-4-hydroxy-6-methyl-2H-pyran-2-one | C6H7NO3 | 83432-20-6 | Details |
3-(Chloromethyl)-6-methoxy-2-methylpyridine | C8H10ClNO | 853569-72-9 | Details |
DBX1 antibody | Details |
tert-Butyl N-(3,4-difluorophenyl)carbamate | C11H13F2NO2 | 144298-04-4 | Details |
EHD2 antibody | Details |
POLM Blocking Peptide | Details |
1-Bromo-4-(1-cyclopropylvinyl)benzene | C11H11Br | 65322-32-9 | Details |
4-Bromo-7-methoxy-1-indanone | C10H9BrO2 | 5411-61-0 | Details |
Minecoside | C25H30O13 | 51005-44-8 | Details |
2-Difluoromethanesulfonylbenzoic acid | C8H6F2O4S | 79676-58-7 | Details |
SH2B3 antibody | Details |
BMPER antibody | Details |
Aphidicolin 17-acetate | C22H36O5 | 51103-57-2 | Details |
(3R,5R)-6-Cyano-3,5-dihydroxy-hexanoic acid tert-butyl ester | C11H19NO4 | 125971-93-9 | Details |
TSPAN15 antibody | Details |
Ac-Ala-Ala-Ala-OH | C11H19N3O5 | 19245-85-3 | Details |
N-Ethylmethylamine | C3H9N | 624-78-2 | Details |
Ethyl 4,7,8-trichloroquinoline-3-carboxylate | C12H8Cl3NO2 | 56824-89-6 | Details |
12-Tridecanoic acid | C13H24O2 | 6006-06-0 | Details |
N,N,3-Trimethylpyrrolidin-3-amine dihydrochloride | 2172503-18-1 | Details |
(4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-5,5-dimethyl-4-(1-methylethyl)-oxazole | C26H28NOP | 1152313-76-2 | Details |
(3-Hydroxyphenyl)acetone | C9H10O2 | 64479-84-1 | Details |
GAPVD1 antibody | Details |
2-(4-bromophenyl)-1-(4-chlorophenyl)-6,6-dimethyl-5,6,7-trihydroindol-4-one | C22H19BrClNO | 902469-90-3 | Details |
N-Fmoc-rhodamine 110 | C35H25ClN2O5 | 293313-27-6 | Details |
4,5,6-Trimethylpyrimidin-2-amine | C7H11N3 | 54568-11-5 | Details |
N-(6-methoxypyridin-3-yl)-1-phenylcyclopentane-1-carboxamide | C18H20N2O2 | 1024197-21-4 | Details |
LYVE1 protein (Mouse) | Details |
Setoxaximab | 1351470-17-1 | Details |
6-Epi-augustifolin | C21H28O6 | 369390-94-3 | Details |
N-benzo[d]1,3-dioxolen-5-yl-2-indolinylethanamide | C17H16N2O3 | 491867-68-6 | Details |
H-ETTVFENLPEK^-OH | Details |
7-Methyl-1-[(7-methyloctyl)oxy]octane | C18H38O | 1461705-92-9 | Details |
1-Cyclopropyl-1H-1,2,3-triazole-5-carboxylic acid | C6H7N3O2 | 1784650-04-9 | Details |
1-(5-Ethyl-4-methylthiophen-2-yl)ethan-1-amine hydrochloride | C9H16ClNS | 1423032-97-6 | Details |
5-Fluoro-1H-1,3-benzodiazole-6-carboxylic acid | C8H5FN2O2 | 1360948-07-7 | Details |
7-(7-Aminoheptanamido)heptanoic acid hydrochloride | C14H29ClN2O3 | 1423034-53-0 | Details |
3-methyl-4-(((4-nitrophenyl)amino)methylene)-1-phenyl-2-pyrazolin-5-one | C17H14N4O3 | 68538-05-6 | Details |
3-Butylpiperazin-2-one | C8H16N2O | 90152-25-3 | Details |
1-Pyridin-2-yl-heptan-1-one oxime | C12H18N2O | 371951-28-9 | Details |
m-dPEG?12-Amido-dPEG?12-TFP Ester | Details |
(3-Bromopropyl)(ethyl)(2,2,2-trifluoroethyl)amine hydrobromide | C7H14Br2F3N | 1461707-37-8 | Details |
tert-Butyl 3-formyl-2,2-dimethylcyclopropane-1-carboxylate | C11H18O3 | 35285-07-5 | Details |
3-(5-Methylthiophen-2-yl)-3-oxopropanenitrile | C8H7NOS | 71683-03-9 | Details |
3,4-Methylenedioxy-5-methoxycinnamic acid | C11H10O5 | 41514-66-3 | Details |
3-Amino-3-(furan-2-yl)propan-1-ol | C7H11NO2 | 683220-42-0 | Details |
8-Hexyloxy-3-(1H-tetrazol-5-yl)-2H-chromen-2-one | C16H18N4O3 | 76239-32-2 | Details |
2-[(3,5-Dimethylphenyl)formamido]acetic acid | C11H13NO3 | 23082-14-6 | Details |
3-(Heptan-3-yl)-1H-pyrazol-5-amine | C10H19N3 | 110086-14-1 | Details |
10,10-difluoro-7-azadispiro[2.0.54.13]decane hydrochloride | C9H14ClF2N | 2097935-51-6 | Details |
2-Benzylaziridine | C9H11N | 13906-90-6 | Details |
Phycoerythrin dye | Details |
5-amino-2-(methylthio)pyrimidine | C5H7N3S | 42382-46-7 | Details |
OR2AT4 Blocking Peptide | Details |
RHOT1 Blocking Peptide | Details |
2-Methanesulfonyl-1,3-thiazole | C4H5NO2S2 | 69749-91-3 | Details |
Product Total: Product Page: | ||||
435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 |